MA12.03 FLAURA2: Resistance, and Impact of Baseline TP53 Alterations in Patients Treated With 1L Osimertinib ± Platinum-Pemetrexed
J.C. Yang, Jacqulyne Robichaux, D. Planchard, K. Kobayashi, Chee Khoon Lee, S. Sugawara, Tsung-Ying Yang, T.M. Kim, Seung‐Whan Kim, N. Yanagitani, A. Markovets, Preetida J. Bhetariya, L. Poole, Yuri Rukazenkov, R. Hartmaier, P.A. Jänne
Topics & Concepts
MedicineOsimertinibPemetrexedPlatinumInternal medicineBaseline (sea)OncologyChemotherapyCancerCisplatinAdenocarcinomaCatalysisGeologyBiochemistryOceanographyROS1ChemistryCancer Treatment and PharmacologyLung Cancer Treatments and MutationsColorectal Cancer Treatments and Studies